Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA

Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results

Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , United States , Laurent Fischer , Anand Reddi , Adverum Biotechnologies Inc , Nasdaq , Drug Administration , Cameraopsin Program For Optogenetics , Factori Program For Dry , Exchange Commission , European Medicines Agency , Healthcare Products Regulatory Agency , Biotechnologies Completes Enrollment , Reports Second Quarter , Star Seyedkazemi , Innovation Passport , Innovative Licensing , Access Pathway , Fast Track Designation , Nonclinical Data , Bilateral Dosing , Equivalent Doses , Pipeline Programs , Geographic Atrophy , Factori Program , Meraopsin Program , Therapeutics License , Three Months Ended June , Fast Track , Private Securities Litigation Reform Act , Quarterly Report , Corporate Strategy , External Affairs ,